A systematic review of short-term outcomes in patients with anti–factor H associated atypical HUS managed with plasma exchanges versus eculizumab

Aditi Sinha, Tanvi Bindal, Federica Zotta, Anne-Laure Sellier-Leclerc, Julien Hogan, Pankaj Hari, Marina Vivarelli, Arvind Bagga

Open source

DOI
10.1007/s00467-026-07309-3
Published
2026-05-08
Container
Pediatric Nephrology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00467-026-07309-3,
  title = {A systematic review of short-term outcomes in patients with anti–factor H associated atypical HUS managed with plasma exchanges versus eculizumab},
  author = {Aditi Sinha and Tanvi Bindal and Federica Zotta and Anne-Laure Sellier-Leclerc and Julien Hogan and Pankaj Hari and Marina Vivarelli and Arvind Bagga},
  year = {2026},
  journal = {Pediatric Nephrology},
  doi = {10.1007/s00467-026-07309-3},
  url = {https://doi.org/10.1007/s00467-026-07309-3}
}

RIS

TY  - JOUR
TI  - A systematic review of short-term outcomes in patients with anti–factor H associated atypical HUS managed with plasma exchanges versus eculizumab
AU  - Aditi Sinha
AU  - Tanvi Bindal
AU  - Federica Zotta
AU  - Anne-Laure Sellier-Leclerc
AU  - Julien Hogan
AU  - Pankaj Hari
AU  - Marina Vivarelli
AU  - Arvind Bagga
PY  - 2026
JO  - Pediatric Nephrology
DO  - 10.1007/s00467-026-07309-3
UR  - https://doi.org/10.1007/s00467-026-07309-3
ER  - 

APA

Sinha, A., Bindal, T., Zotta, F., Sellier-Leclerc, A., Hogan, J., Hari, P., Vivarelli, M., & Bagga, A. (2026). A systematic review of short-term outcomes in patients with anti–factor H associated atypical HUS managed with plasma exchanges versus eculizumab. Pediatric Nephrology. https://doi.org/10.1007/s00467-026-07309-3

Source records